Regional treatments including chemotherapy have been applied to patients with malignant
melanoma metastasis to the liver in clinical trials, but with limited efficacy. To improve …

ABSTRACT Background/Aims: Liver is the most common site of metastases in uveal
melanoma. Hepatic arterial infusion of cytotoxic agents may be an effective method of …

Background and Objectives Ocular melanoma has a predilection for liver metastases.
Systemic treatment is ineffective and the optimal regional therapy approach is poorly …

The liver is the primary site of metastases in most uveal melanoma patients. We
retrospectively investigated intraarterial chemotherapy (IAC) as treatment for patients with …

Chemotherapy remains an important approach for the treatment of liver metastases from
uveal melanoma (UM). Compared with systemic chemotherapy, regional chemotherapy has …

Ocular melanoma has a unique metastatic predilection for the liver and is refractory to most
forms of therapy. The dual blood supply of the liver with differential perfusion of metastatic …

Objectives: Hepatic arterial infusion (HAI) of cytotoxic chemotherapy is a strategy to deliver
high dose of anticancer therapy to liver metastases that derive their blood supply from the …

Ocular melanoma is the most common primary ocular malignancy and has a significant
predilection for metastasis to the liver. More than 40% of patients have hepatic metastases …

Uveal melanoma is the most common primary intraocular tumour in adults. After treatment of
the primary tumour, up to 50% of patients will ultimately develop metastases. Treatment …

Aim To evaluate the outcomes of isolated liver chemo perfusion in patients with hepatic
metastases from uveal melanoma. Materials and methods Cardiovascular surgeons are …